Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1376
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanda, Amulya Kumar-
dc.contributor.authorPatnaik, Soma-
dc.contributor.authorMohanty, Biswaranjan-
dc.contributor.authorMajumdar, Dipak K-
dc.contributor.authorMishra, Sagar K-
dc.date.accessioned2022-06-14T10:28:45Z-
dc.date.available2022-06-14T10:28:45Z-
dc.date.issued2015-06-
dc.identifier.urihttp://hdl.handle.net/123456789/1376-
dc.description.abstractThe purpose of this study was to investigate the feasibility of entrapping water-insoluble drug itraconazole into solid lipid nanoparticles (SLNs) for topical ocular delivery. The drug-loaded SLNs were prepared from stearic acid and palmitic acid using different concentrations of polyvinyl alcohol employed as emulsifier. SLNs were prepared by the melt-emulsion sonication and low temperature-solidification method and characterized for particle size, zeta potential, drug loading and drug entrapment efficiency. The mean particle size of SLNs prepared with stearic acid ranged from 139 to 199 nm, while the SLNs prepared with palmitic acid had particle size in the range of 126-160 nm. The SLNs were spherical in shape. Stearic acid-SLNs showed higher entrapment of drug compared with palmitic acid-SLNs. Differential scanning calorimetry (DSC) and X-ray diffraction measurements showed decrease in crystallinity of drug in the SLN formulations. The modified Franz-diffusion cell and freshly excised goat corneas were used to test drug corneal permeability. Permeation of itraconazole from stearic acid-SLNs was higher than that obtained with palmitic acid-SLNs. The SLNs showed clear zone of inhibition against Aspergillus flavus indicating antimicrobial efficacy of formulations.en_US
dc.language.isoenen_US
dc.publisherInforma Healthcare USA, Incen_US
dc.subjectItraconazole; palmitic acid; permeation; solid lipid nanoparticles; stearic aciden_US
dc.titleDevelopment and characterization of itraconazole-loaded solid lipid nanoparticles for ocular deliveryen_US
dc.typeArticleen_US
dc.journalPharm Dev Technolen_US
dc.volumeno20en_US
dc.issueno4en_US
dc.pages458-464en_US
Appears in Collections:Product Development Cell Unit- II, Publications

Files in This Item:
File Description SizeFormat 
Pharm Dev Technol, 2015; 20(4) 458–464.pdf1.11 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.